Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 240, pseudogene (RN7SL240P)

Target
RN7SL240P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

**RNA, 7SL, cytoplasmic 240, pseudogene (RN7SL240P)** is a human **pseudogene** derived from the 7SL RNA gene family[5]. 7SL RNA is an essential component of the **signal recognition particle (SRP)**, which is critical for directing newly synthesized proteins to the endoplasmic reticulum in eukaryotic cells[1]. However, **RN7SL240P** does not code for a functional product; it is a truncated and/or mutant copy of the original 7SL RNA gene that was inserted into the human genome through retrotransposition or related mechanisms and is categorized as a **processed pseudogene**[3]. While some pseudogenes can play regulatory roles—such as acting as non-coding RNA regulators or competitive endogenous RNAs (ceRNAs)—there are no direct reports of RN7SL240P itself having such activity or clinical or therapeutic significance[2][5]. Thus, **RN7SL240P is not considered a therapeutic target, enzyme, receptor, or regulator**.

Other names
RN7SL240PRNA, 7SL, Cytoplasmic 240, Pseudogene
02

Biological functions

Potential regulatory roles through RNA-mediated regulation (general for pseudogenes; not specifically reported for RN7SL240P)
03

Disease associations

Other (no specific roles in disease reported for RN7SL240P; some pseudogenes regulate genes involved in cancer and other diseases[2])

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 240, pseudogene (RN7SL240P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 240, pseudogene (RN7SL240P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call